Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2906
Full Text
Open PDFAbstract
Available in full text
Date
May 26, 2009
Authors
Publisher
American Association for Cancer Research (AACR)